DODGE & COX – BioMarin Pharmaceutical Inc. Transaction History
DODGE & COX portfolio value:
$1.25B
portfolio value
DODGE & COX quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.55% | -233.1K shares | 8.75M | $84.77 | 14.77M |
| Q2 2022 | share | Decrease | -0.19% | -27.93K shares | 84.43M | $82.87 | 15.00M |
| Q1 2022 | share | Increase | +1.42% | 209.95K shares | -150.59M | $77.1 | 15.03M |
| Q4 2021 | share | Increase | +0.04% | 6.46K shares | 164.46M | $89.08 | 14.82M |
| Q3 2021 | share | Increase | +5.08% | 716.48K shares | -31.35M | $77.29 | 14.81M |
| Q2 2021 | share | Increase | +18.96% | 2.24M shares | 281.56M | $83.44 | 14.10M |
| Q1 2021 | share | Increase | +21.00% | 2.05M shares | 36.02M | $75.51 | 11.85M |
| Q4 2020 | share | Increase | +26.90% | 2.07M shares | 271.73M | $87.69 | 9.79M |
| Q3 2020 | share | Increase | +113.52% | 4.10M shares | 141.39M | $76.08 | 7.72M |
| Q2 2020 | share | Decrease | -8.29% | -326.76K shares | 112.82M | $123.34 | 3.61M |
| Q1 2020 | share | Decrease | -10.18% | -447.00K shares | -37.99M | $84.5 | 3.94M |
| Q4 2019 | share | Increase | 0.00% | 4.38M shares | 371.13M | $84.55 | 4.38M |